The first stop for professional medicines advice

Medicines planning

63 results

Applied filters

Good governance when implementing natalizumab biosimilar

6 February 2024Governance should consider processes for approval, procurement and supply, prescribing and administration, monitoring and pharmacovigilance.

The licence and supporting evidence for natalizumab biosimilar

6 February 2024One licensed natalizumab biosimilar is available: Tyruko. Learn about the licensed indications and supporting evidence.

SPS Horizon Scanning

20 January 2024Know what medicines are in the pipeline. Understand the strategic and operational challenges for the NHS. Start planning early.

Considerations for developing national PGD templates

3 January 2024Decisions to develop PGD templates under the national Medicines Governance Do Once Programme depend on a variety of factors and advice on exclusions is given.

Understanding Patient Group Directions and Integrated Care Boards

3 May 2023We outline the responsibilities of ICBs in England as commissioners of NHS services using PGDs, and link to resources that provide further support and advice.

PGD use in Hospital at Home services, including Virtual Wards

28 March 2023Considerations required before implementing Patient Group Direction (PGDs) in Hospital at Home, including virtual ward, services

Choosing between available adalimumab products

22 February 2023Understand the adalimumab products that are available on contract to the NHS. Choose between them appropriately for organisations or individuals.

New Medicines News

5 January 2023
Registration required

Annual medicines planning publication, Prescribing Outlook

28 October 2022Our annual output to support managed entry and budget planning for new medicines, new indications and patent expiries in the NHS.

Costing Clinical Trials of ATIMPs using the NIHR iCT - Advice for Pharmacy Sites

12 July 2022Guidance to support and promote consistent pharmacy costing for commercial clinical trials involving ATIMPs.
admin